The mission of The Leukemia & Lymphoma Society (LLS): Cure leukemia, lymphoma, Hodgkin's disease and myeloma, and improve the quality of life of patients and their families. LLS has dedicated itself to being one of the top-rated voluntary health agencies in terms of dollars that directly fund our mission.
Strategic Plan: 2008 - 2011
Highlights
The North Star 2015 Vision describes a future which LLS's volunteers and staff aspire to create. It is a future in which LLS will have transformed the lives of people with blood cancer and the healthcare landscape that patients and their families and caregivers navigate.
The following highlights the changes our organization must make in order to advance toward the Vision outcomes. These changes will transform our missionarea programs, our revenue generation model and the culture of our organization.
The organization will significantly increase its annual net revenue by adding new strategies to its revenue-generating practices:
-
Diversify LLS's revenue sources by making donor development an organization-wide priority
-
Identify and develop new income streams outside traditional donor development and campaign models
-
Grow Canadian resources
-
Continue to grow priority campaigns and develop product and market extensions
In order to achieve all of the above changes, LLS will transform its culture and become a world-class volunteer and staff organization. We will:
-
Integrate the Vision into all aspects of LLS's work, ensuring that it guides all of the activities of our staff and volunteers
-
Develop superior capabilities in staff and volunteers through emphasis on selection, training, development and education
-
Form strategic collaborations and partnerships
-
Increase effectiveness of all staff and volunteers through better application of technology
-
Across the organization, implement programs that diversify the populations comprising our patients, staff and volunteers
Substantial increases in funding for mission programs during 2008-2011 will allow us to:
-
Accelerate the development of new therapies
-
Increase participation in blood cancer clinical trials
-
Provide navigation assistance to patients at all points in their cancer journeys
-
Make services and information available to 50 percent of all patients within 30 days of diagnosis
